Pulmonx
LUNG
123 hedge funds and large institutions have $456M invested in Pulmonx in 2023 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 42 increasing their positions, 37 reducing their positions, and 13 closing their positions.
2,676% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $38K
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
33% more capital invested
Capital invested by funds: $344M → $456M (+$113M)
14% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 37
5.87% more ownership
Funds ownership: 87.57% → 93.45% (+5.9%)
5% more funds holding
Funds holding: 117 → 123 (+6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.4M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$14.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.3M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.98M |
| 5 |
Millennium Management
New York
|
+$4.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$14.4M |
| 2 |
DM
Deerfield Management
New York
|
-$10.5M |
| 3 |
Walleye Capital
New York
|
-$3.85M |
| 4 |
PVI
Pura Vida Investments
New York
|
-$2.59M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
-$2.09M |
LUNG Hedge Fund Activity: Q4 2023 in Review
123 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Pulmonx (LUNG) for Q4 2023, worth a combined $456M — up 33% from $344M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new LUNG positions and 13 closed out — a net gain of 8 holders — while 42 added to existing stakes and 37 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $24.4M. The largest seller was Point72 Asset Management, cutting an estimated $14.4M.
- 123 institutional investors held Pulmonx (LUNG) as of Q4 2023, up from 117 in Q3 2023.
- Funds reported $456M of Pulmonx stock for Q4 2023, up 33% quarter-over-quarter.
- 21 funds opened new Pulmonx positions in Q4 2023 and 13 closed out, a net change of +8 holders.
- The largest Pulmonx buyer in Q4 2023 was Morgan Stanley, an estimated $24.4M added.
- The largest Pulmonx seller in Q4 2023 was Point72 Asset Management, an estimated $14.4M sold.
Based on aggregated 13F filings for Q4 2023.